4月2日 - ** 券商瑞银将人寿与健康再保险公司美国再保险集团RGA.N的评级从 "买入 "下调至 "中性"；将目标价从250美元下调至216美元
** 指出年度资本部署目标以及Equitable Holdings EQH.N交易的执行风险 (link)
** 称随着管理层执行其更新、更激进的增长战略，近期的股价风险将在短期内持续存在
** 券商表示："依赖第三方资本来满足每股收益的增长，对于一向以保守着称的全球再保险专营权来说，可能会被视为'捉襟见肘'"。
** 12家券商中有9家将股票评级定为 "买入 "或更高，3家为 "持有"；PT中值为250美元--LSEG数据
** 包括盘中走势在内，RGA股价今年累计下跌约6.7%，而标准普尔500指数.SPX下跌4.2%。
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.